Oppenheimer raises Tarsus Pharmaceuticals target price to $103 from $100
TARS•Oppenheimer raised its target price for Tarsus Pharmaceuticals to $103 from $100.
Related News
Royale Energy to begin trading on OTCQB Venture Market Nov. 4
ROYL•
Northrop Grumman to present at Baird Global Industrial Conference
NOC•
CoStar raises near-term US retail forecast
CSGP•
Lyell Immunopharma's ronde-cel achieves 77% complete response rate in pivotal lymphoma trial
LYEL•
Flowers Foods elects Shaun Mara, Ken Plunk as independent directors
FLO•